当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Yoshihide Ogawa, Rensuke Mannami, Makoto Mannami, Mitsuo Nishi and Naoki Mitsuhata
We coined the term “therapeutic kidney donation” specifically in reference to donatable kidneys that have been nephrectomized due to urologic diseases and reviewed various series of reports and empirical sporadic reports. Kidneys with small renal tumors and distal ureter tumors in addition to benign kidney pathologies have historically been used for transplantation. Some ethical problems exist in cases in which therapeutic donor kidneys are used for unrelated living transplantation but not for related transplantation. Therefore, a well-organized national project, such as the OPTN policy, is awaited. Kidneys with small renal masses are an attractive source for donation, but these organs have several unsolved problems, including locally advanced stages, high histological grades, multifocality, and distant metastasis. Further clinical studies are warranted to organize and recruit proper therapeutic kidney donation for restored kidney transplantation.